Cue Biopharma Inc
(CUE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 8,254 | 2,395 | 2,739 | 1,553 | 475 |
| Gross Profit | 8,254 | 2,395 | 2,739 | 1,553 | 475 |
| Operating Expenses | 16,127 | 15,413 | 13,042 | 14,071 | 11,450 |
| Operating Income | -7,873 | -13,018 | -10,303 | -12,518 | -10,975 |
| Other Income | -16 | 25 | 24 | 13 | 78 |
| Pre-tax Income | -7,889 | -12,993 | -10,279 | -12,505 | -10,897 |
| Net Income Continuous | -8,384 | -12,993 | -10,279 | -12,505 | -11,103 |
| Net Income | $-8,384 | $-12,993 | $-10,279 | $-12,505 | $-11,103 |
| EPS Basic Total Ops | -0.26 | -0.41 | -0.33 | -0.41 | -0.36 |
| EPS Basic Continuous Ops | -0.26 | -0.41 | -0.33 | -0.41 | -0.36 |
| EPS Diluted Total Ops | -0.26 | -0.41 | -0.33 | -0.41 | -0.36 |
| EPS Diluted Continuous Ops | -0.26 | -0.41 | -0.33 | -0.41 | -0.36 |
| EBITDA(a) | $-7,563 | $-12,702 | $-9,989 | $-12,205 | $-10,714 |